Article info
PDFEditorial
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
- Correspondence to Dr Margaret Gatti-Mays; margaret.gatti-mays{at}osumc.edu
Citation
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
Publication history
- Accepted January 12, 2021
- First published February 18, 2021.
Online issue publication
November 23, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2021 https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.